Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Genetic predisposition and modifiable risks for late-life dementia

Modifiable lifestyle risk factors are able to reduce dementia risk only in people with low genetic risk.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: The interaction between genetics and lifestyle on dementia risk.


  1. 1.

    Licher, S. et al. Nat. Med. (2019).

  2. 2.

    Lourida, I. et al. J. Am. Med. Assoc. (2019).

    Article  Google Scholar 

  3. 3.

    Lyall, D. M. et al. Neurology 92, e2691–e2698 (2019).

    Article  Google Scholar 

  4. 4.

    Dekhtyar, S. et al. Ann. Neurol. 86, 68–78 (2019).

    CAS  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Canevelli, M. et al. Front. Neurol. 8, 628 (2017).

    Article  Google Scholar 

  6. 6.

    Rogers, N. T., Steptoe, A. & Cadar, D. Sci. Rep. 7, 15746 (2017).

    Article  Google Scholar 

  7. 7.

    Wallace, L. M. K. et al. Lancet Neurol. 18, 177–184 (2019).

    Article  Google Scholar 

  8. 8.

    MacLullich, A. M., Beaglehole, A., Hall, R. J. & Meagher, D. J. Int. Rev. Psychiatry 21, 30–42 (2009).

    Article  Google Scholar 

  9. 9.

    Persico, I. et al. J. Am. Geriatr. Soc. 66, 2022–2030 (2018).

    Article  Google Scholar 

  10. 10.

    Adamis, D., Devaney, A., Shanahan, E., McCarthy, G. & Meagher, D. Age Ageing 44, 318–321 (2015).

    Article  Google Scholar 

  11. 11.

    Davis, D. H. et al. JAMA Psychiatry 74, 244–251 (2017).

    Article  Google Scholar 

  12. 12.

    Livingston, G. et al. Lancet 390, 2673–2734 (2017).

    Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Kenneth Rockwood.

Ethics declarations

Competing interests

In addition to academic and hospital appointments, K.R. is President and Chief Science Officer of DGI Clinical, which in the past 5 years has contracts with pharma and device manufacturers (Baxter, Baxalta, Biogen, Shire, Hollister, Nutricia, Roche, Otsuka) on individualized outcome measurement. In 2017, he attended an advisory board meeting with Lundbeck. Otherwise, any personal fees are for invited guest lectures, rounds and academic symposia, received directly from event organizers, for presentations on frailty. He is Associate Director of the Canadian Consortium on Neurodegeneration in Aging, which is funded by the Canadian Institutes of Health Research (CAN-137794), with additional funding from the Alzheimer Society of Canada and several other charities, as well as from Pfizer Canada and Sanofi Canada (in Phase 1, 2014–2019). He receives career support from the Dalhousie Medical Research Foundation as the Kathryn Allen Weldon Professor of Alzheimer Research, and research support through grants from the Canadian Institutes of Health Research, the Canadian Frailty Network, the Nova Scotia Health Research Foundation, the Nova Scotia Health Authority Research Fund and the Fountain Family Innovation Fund of the QEII Health Science Centre Foundation.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Rockwood, K., Wallace, L.M.K. & Davis, D.H. Genetic predisposition and modifiable risks for late-life dementia. Nat Med 25, 1331–1332 (2019).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing